Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Squamous Cell Carcinoma of the Head and Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT00588770
What this trial is testing

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Neck Squamous Cell Carcinoma of Unknown PrimaryRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell Carcinoma+32 more
National Cancer Institute (NCI) 403
Testing effectiveness (Phase 2)Looking for participantsNCT06648096
What this trial is testing

Afatinib in Patients With Fanconi Anemia (FA) and Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)

Who this might be right for
Fanconi AnemiaHead and Neck Squamous Cell Carcinoma
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 25
Post-approval studies (Phase 4)Looking for participantsNCT07405086
What this trial is testing

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

Who this might be right for
Advanced Biliary Tract CarcinomaAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Hepatocellular Carcinoma+18 more
OHSU Knight Cancer Institute 160
Testing effectiveness (Phase 2)Looking for participantsNCT07485296
What this trial is testing

Effect of Postbiotics on Microbiota and Systemic Immunomodulation of Pembrolizumab as First-Line Therapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (RM HNSCC)

Who this might be right for
Head & Neck Squamous Cell Carcinoma
Gruppo Oncologico del Nord-Ovest 45
Testing effectiveness (Phase 2)UnknownNCT01830556
What this trial is testing

Randomised Phase II, Cetuximab in Combination With 5FU and Cisplatin or Carboplatin Versus Cetuximab in Combination With Paclitaxel and Carboplatin for Treatment of Patients With Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Karolinska University Hospital 120
Large-scale testing (Phase 3)Study completedNCT02358031
What this trial is testing

Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)

Who this might be right for
Recurrent Head and Neck CancerMetastatic Head and Neck Cancer
Merck Sharp & Dohme LLC 882
Not applicableLooking for participantsNCT04068155
What this trial is testing

Alpha Radiation Emitters Device (DaRT) for the Treatment of of Malignant Cutaneous Tumors

Who this might be right for
Skin CancerCutaneous TumorCutaneous Metastasis
Alpha Tau Medical LTD. 80
Testing effectiveness (Phase 2)Study completedNCT01528163
What this trial is testing

Study Comparing Two Treatments in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 101
Testing effectiveness (Phase 2)Study completedNCT00066716
What this trial is testing

Celecoxib, Paclitaxel, and Carboplatin in Treating Patients With Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
Weill Medical College of Cornell University 39
Testing effectiveness (Phase 2)Looking for participantsNCT07088211
What this trial is testing

Sacituzumab Tirumotecan and Toripalimab in the First-line Treatment of HNSCC

Who this might be right for
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 39
Not applicableWithdrawnNCT01075841
What this trial is testing

A Post-marketing Surveillance Study on Erbitux in Combination With Platinum-based Chemotherapy in Metastatic/Recurrent Squamous Cell Cancer of the Head and Neck

Who this might be right for
Neoplasms, Squamous Cell
Merck KGaA, Darmstadt, Germany
Testing effectiveness (Phase 2)UnknownNCT05522894
What this trial is testing

AK104 Alone or in Combination With Chemotherapy in the First-line Treatment of ESCC

Who this might be right for
Unresectable Esophageal Squamous Cell CarcinomaLocally Advanced Esophageal Squamous Cell CarcinomaMetastatic Esophageal Squamous Cell Carcinoma
Chinese Academy of Medical Sciences 80
Testing effectiveness (Phase 2)Ended earlyNCT02488629
What this trial is testing

Study of SCB01A in Patient With Head and Neck Cancer

Who this might be right for
Head and Neck Squamous Cell Carcinoma
SynCore Biotechnology Co., Ltd. 5
Testing effectiveness (Phase 2)Study completedNCT04220866
What this trial is testing

Study of Intratumoral (IT) Ulevostinag (MK-1454) in Combination With Intravenous (IV) Pembrolizumab (MK-3475) Compared to IV Pembrolizumab Alone as the First Line Treatment of Metastatic or Unresectable, Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC) (MK-1454-002)

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)
Merck Sharp & Dohme LLC 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07840456
What this trial is testing

Safety and Efficacy of Ruxolitinib in Patients With HNSCC and High NLR Treated With Pembrolizumab - The Phase 2 InflammaSTOP Trial

Who this might be right for
Carcinoma, Squamous Cell of Head and Neck HNSCC
University Hospital, Basel, Switzerland 66
Testing effectiveness (Phase 2)UnknownNCT05136768
What this trial is testing

Sintilimab Combined With Chemotherapy and SBRT in Limited Metastatic Head and Neck Squamous Cell Carcinoma (LM-HNSCC)

Who this might be right for
Head and Neck Squamous Cell CarcinomaMetastasesImmunotherapy+1 more
Jun-Lin Yi, MD 50
Not applicableUnknownNCT00173849
What this trial is testing

The Role of SDF-1/CXCR4 in Metastasis of Oral Squamous Cell Carcinoma

Who this might be right for
Oral Cancer
National Taiwan University Hospital 100
Testing effectiveness (Phase 2)Looking for participantsNCT06975410
What this trial is testing

Clinical Trial of YH32364 in Patients With Locally Advanced or Metastatic EGFR Overexpressing Solid Tumors

Who this might be right for
EGFR OverexpressionLocally Advanced Solid TumorMetastatic Solid Tumor
Yuhan Corporation 80
Testing effectiveness (Phase 2)Study completedNCT01289522
What this trial is testing

Chemotherapy With Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Squamous Cell Head and Neck CarcinomaRecurrent or Metastatic Disease
Groupe Oncologie Radiotherapie Tete et Cou 54
Testing effectiveness (Phase 2)Study completedNCT01040832
What this trial is testing

EMD 1201081 in Combination With Cetuximab in Second-Line Cetuximab-Naïve Subjects With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck Cancer
EMD Serono 107
Next Page